FDA Approved: SOTRADECOL — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved a supplemental application for SOTRADECOL (tetradecyl hydrogen sulfate ester) submitted by Mylan Institutional LLC under ANDA040541.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicose Veins

Drugs mentioned

• SOTRADECOL (Sodium tetradecyl sulfate)

Snippet

SUPPL AP for SOTRADECOL (TETRADECYL HYDROGEN SULFATE (ESTER))